Evaluation of ethanol leaf extract of Ocimum sanctum in experimental models of anxiety and depression

References

• Adzu B, Amos S, Muazzam I, Inyang US, Gamaniel KS. (2002). Neuropharmacological screening of Diospyros mespiliformis in mice. J Ethnopharmacol 83:139–143.
   PubMed Web of Science ®Google Scholar
• Asha MK, Prashanth D, Murali B, Padmaja R, Amit A. (2001). Anthelmintic activity of essential oil of Ocimum sanctum and eugenol. Fitoterapia 72:669–670.
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ. (2006). Drug therapy of depression and anxiety disorders. In: Brunton LL, Lazo JS, Parker KL, eds. Goodmann and Gillmann’s the Pharmacological Basis of Therapeutics. New York: McGraw-Hill, pp. 429–459.
   Google Scholar
• Barkow K, Heun R, Wittchen HU, Bedirhan Ustün T, Gänsicke M, Maier W. (2004). Mixed anxiety-depression in a 1 year follow-up study: Shift to other diagnoses or remission? J Affect Disord 79:235–239.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya D, Sur TK, Jana U, Debnath PK. (2008). Controlled programmed trial of Ocimum sanctum leaf on generalized anxiety disorders. Nepal Med Coll J 10:176–179.
   PubMedGoogle Scholar
• Chatterjee M, Verma P, Palit G. (2010). Comparative evaluation of Bacopa monnera and Panax ginseng in experimental anxiety and depressive models in mice. Indian J Exp Biol 48:306–313.
   PubMed Web of Science ®Google Scholar
• Crawley J, Goodwin FK. (1980). Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 13:167–170.
   PubMed Web of Science ®Google Scholar
• Dharmani P, Kuchibhotla VK, Maurya R, Srivastava S, Sharma S, Palit G. (2004). Evaluation of anti-ulcerogenic and ulcer-healing properties of Ocimum sanctum Linn. J Ethnopharmacol 93:197–206.
   PubMed Web of Science ®Google Scholar
• Dunham NW, Miya TS. (1957). A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc (Baltim) 46:208–209.
   PubMed Web of Science ®Google Scholar
• Geetha RK, Vasudevan DM. (2004). Inhibition of lipid peroxidation by botanical extracts of Ocimum sanctum: in vivo and in vitro studies. Life Sci 76:21–28.
   PubMed Web of Science ®Google Scholar
• Godhwani S, Godhwani JL, Vyas DS. (1987). Ocimum sanctum: an experimental study evaluating its anti-inflammatory, analgesic and antipyretic activity in animals. J Ethnopharmacol 21:153–163.
   PubMed Web of Science ®Google Scholar
• Gupta P, Yadav DK, Siripurapu KB, Palit G, Maurya R. (2007). Constituents of Ocimum sanctum with antistress activity. J Nat Prod 70:1410–1416.
   PubMed Web of Science ®Google Scholar
• Gupta S, Mediratta PK, Singh S, Sharma KK, Shukla R. (2006). Antidiabetic, antihypercholesterolaemic and antioxidant effect of Ocimum sanctum (Linn) seed oil. Indian J Exp Biol 44:300–304.
   PubMedGoogle Scholar
• Haefely W. (1992). The role of GABA in anxiolytic/antidepressant drug action. In: Elliott JM, Heal DJ, Marsden CA, eds. Experimental Approaches to Anxiety and Depression. Chichester: John Wiley, pp. 151–168.
   Google Scholar
• Hogg S. (1996). A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54:21–30.
   PubMed Web of Science ®Google Scholar
• Karthikeyan K, Gunasekaran P, Ramamurthy N, Govindasamy S. (1999). Anticancer activity of Ocimum sanctum. Pharm Biol 37:285–290.
   Web of Science ®Google Scholar
• Labrid C, Mocaër E, Kamoun A. (1992). Neurochemical and pharmacological properties of tianeptine, a novel antidepressant. Br J Psychiatry 160:56–60.
   Web of Science ®Google Scholar
• Lister RG. (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92:180–185.
   PubMed Web of Science ®Google Scholar
• Moreira EG, Nascimento N, Rogero JR, Vassilieff VS. (2000). Gabaergic-benzodiazepine system is involved in the crotoxin-induced anxiogenic effect. Pharmacol Biochem Behav 65:7–13.
   PubMed Web of Science ®Google Scholar
• Murphy DL, Mitchell PB, Potter WZ. (1995). Novel pharmacological approaches to the treatment of depression. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: Fourth Generation of Progress. New York: Raven Press, pp. 1143–1153.
   Google Scholar
• Porsolt RD, Le Pichon M, Jalfre M. (1977). Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730–732.
   PubMed Web of Science ®Google Scholar
• Reus VI. (2008). Mental disorders. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J, eds. Harrison’s Principles of Internal Medicine. New York: McGraw-Hill, pp. 2710–2723.
   Google Scholar
• Samson J, Sheela Devi R, Ravindran R, Senthilvelan M. (2006). Biogenic amine changes in brain regions and attenuating action of Ocimum sanctum in noise exposure. Pharmacol Biochem Behav 83:67–75.
   PubMed Web of Science ®Google Scholar
• Sanberg PR, Zoloty SA, Willis R, Ticarich CD, Rhoads K, Nagy RP, Mitchell SG, Laforest AR, Jenks JA, Harkabus LJ. (1987). Digiscan activity: automated measurement of thigmotactic and stereotypic behavior in rats. Pharmacol Biochem Behav 27:569–572.
   PubMed Web of Science ®Google Scholar
• Shader RI, Greenblatt DJ. (1995). Pharmacotherapy of acute anxiety. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: Fourth Generation of Progress. New York: Raven Press, pp. 1341–1348.
   Google Scholar
• Singh S, Malhotra M, Majumdar DK. (2005). Antibacterial activity of Ocimum sanctum L. fixed oil. Indian J Exp Biol 43:835–837.
   PubMedGoogle Scholar
• Steru L, Chermat R, Thierry B, Simon P. (1985). The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology (Berl) 85:367–370.
   PubMed Web of Science ®Google Scholar
• Takeda H, Tsuji M, Miyamoto J, Matsumiya T. (2002). Rosmarinic acid and caffeic acid reduce the defensive freezing behavior of mice exposed to conditioned fear stress. Psychopharmacology (Berl) 164:233–235.
   PubMed Web of Science ®Google Scholar
• The World Health Report (WHO). (2001). Mental Health: New Understanding, New Hope. Geneva. Retrieved from http://www.who.int/whr/2001/en/whr01_en.pdf
   Google Scholar
• Walter G, Rey JM. (1999). The relevance of herbal treatments for psychiatric practice. Aust NZ J Psychiatry 33:482–489; discussion 490–493.
   PubMed Web of Science ®Google Scholar
• Weissman MM, Markowitz JS, Ouellette R, Greenwald S, Kahn JP. (1990). Panic disorder and cardiovascular/cerebrovascular problems: Results from a community survey. Am J Psychiatry 147:1504–1508.
   PubMed Web of Science ®Google Scholar
• Willner P, Muscat R. (1991). Animal models for investigating the symptoms of depression and the mechanisms of action of antidepressant drugs. In: Oliver B, Mos J, Slagen J, eds. Animal Models in Psychopharmacology: Advances in Pharmacology Sciences. Birkhäuser Verlag Basel, pp. 183–198.
   Google Scholar
• Yocca FD. (1990). Neurochemistry and neurophysiology of buspirone and gepirone: Interactions at presynaptic and postsynaptic 5-HT1A receptors. J Clin Psychopharmacol 10:6S–12S.
   PubMedGoogle Scholar
• Young R, Johnson DN. (1991). A fully automated light/dark apparatus useful for comparing anxiolytic agents. Pharmacol Biochem Behav 40:739–743.
   PubMed Web of Science ®Google Scholar
• Zhang ZJ. (2004). Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Life Sci 75:1659–1699.
   PubMed Web of Science ®Google Scholar